|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/60 | (2017.01) |
| A61K 47/60 | (2017.08) | ||
| A61K 47/59 | (2017.01) | ||
| A61K 47/59 | (2017.08) | ||
| A61K 47/593 | (2017.08) | ||
| A61K 47/64 | (2017.01) | ||
| A61K 47/643 | (2017.08) | ||
| A61K 47/68 | (2017.01) | ||
| A61K 38/26 | (2006.01) | ||
| A61K 47/6435 | (2017.08) | ||
| A61P 1/16 | (2006.01) | ||
| A61K 47/68 | (2017.08) | ||
| A61P 3/00 | (2006.01) | ||
| A61K 47/6811 | (2017.08) | ||
| A61P 3/04 | (2006.01) | ||
| A61P 1/16 | (2018.01) | ||
| A61P 3/06 | (2006.01) | ||
| A61P 3/00 | (2018.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61P 3/04 | (2018.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61P 31/14 | (2018.01) | ||
| A61P 31/14 | (2006.01) | ||
| A61P 31/20 | (2018.01) | ||
| A61P 31/20 | (2006.01) | ||
| A61P 3/06 | (2018.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 9/10 | (2018.01) | ||
| A61P 3/10 | (2018.01) | ||
| A61K 38/26 | (2013.01) |
| (11) | Number of the document | 2884994 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13823727.6 |
| Date of filing the European patent application | 2013-07-25 | |
| (97) | Date of publication of the European application | 2015-06-24 |
| (45) | Date of publication and mention of the grant of the patent | 2023-01-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/KR2013/006668 |
| Date | 2013-07-25 |
| (87) | Number | WO 2014/017843 |
| Date | 2014-01-30 |
| (30) | Number | Date | Country code |
| 20120081475 | 2012-07-25 | KR |
| (72) |
JUNG, Sung Youb , KR
KIM, Jin-Sun , KR
JANG, Myung Hyun , KR
LEE, Sang Hyun , KR
CHOI, In Young , KR
KWON, Se Chang , KR
|
| (73) |
Hanmi Pharm. Co., Ltd. ,
214 Muha-ro
Paltan-myeon, Hwaseong-si, Gyeonggi-do 445-958,
KR
|
| (54) | COMPOSITION FOR TREATING HYPERLIPIDEMIA COMPRISING OXYNTOMODULIN DERIVATIVE |
| COMPOSITION FOR TREATING HYPERLIPIDEMIA COMPRISING OXYNTOMODULIN DERIVATIVE |